サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439252

薬液注入システム - 世界市場の考察、競合情勢、市場予測（2030年）

Drug Infusion System - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
薬液注入システム - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の薬液注入システムの市場規模は、2023年に117億3,000万米ドル、2030年までに194億5,000万米ドルに達し、2024年～2030年の予測期間にCAGRで8.85％の成長が見込まれます。薬液注入システムの需要は主に、がん、糖尿病などの慢性疾患の有病率の上昇、老年人口の増加、製品開発における技術の進歩などによって促進されています。

薬液注入システムの市場力学

薬液注入システム市場は、さまざまながんなどの慢性疾患の有病率の上昇により、予測期間に大きな成長を記録する見込みです。例えば、世界保健機関（WHO）（2022）が引用したデータによると、2020年に世界で約226万件の乳がん、221万件の肺がん、193万件の大腸がん、141万件の前立腺がん、109万件の胃がんが報告されています。

国際糖尿病連合（IDF）（2023）が発表した統計によると、2021年に全世界で5億3,700万人の成人が糖尿病を患っていました。この数は2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると予測されています。

上記の事実は、世界中で急増しているがんや慢性疾患の一例です。慢性疾患は多くの場合、生涯にわたって個人に影響を及ぼし、長期にわたる治療介入が必要となります。そのために用いられるのが薬液注入システムです。薬液注入システムは、抗生物質、鎮痛剤、ホルモン剤、化学療法剤などの薬剤や栄養素を患者にデリバリーする医療機器です。これらのシステムは、固定式や移動式などのさまざまな構成で利用できます。これらのデバイスは、投与量を常に確認する必要がなく、安全で正確なドラッグデリバリーを実現します。

さらに、技術の進歩により、プログラムマブル薬液注入システムが開発され、投与量を簡単に追跡できる流量やアラームなどの機能が提供されています。例えば、B. Braun Melsugen AGのSpace ecosystemは、OnlineSuiteplusを搭載した統合輸液システムです。この統合システムは、接続性とデータ管理、標準化された相互運用性、卓越した治療、クラウドベースアプリケーションなどの機能を提供します。

しかし、製品のリコールに加え、接続切れやキャリブレーションの問題などの輸液システムに関連する技術的問題が、薬液注入システム市場の成長に対する一定の抑制要因になる可能性があります。

薬液注入システム市場のセグメント分析

薬液注入システム市場の製品セグメントでは、シリンジベースの注入システムが大きなシェアを占めると推定されます。

これは、製品設計がシンプルで適用範囲が広いためです。

シリンジポンプは臨床環境で広く使用されています。そのため、シリンジをシステムに取り付け、要件に応じてドラッグデリバリーをプログラムします。

これらのシステムは、少量の薬剤が必要な場合に便利です。

シリンジ注入システムは、特に乳児、新生児、幼児などの低年齢の患者への投与に最適です。

したがって、シリンジ注入システムが提供する利点により、予測期間にその需要は増加します。

北米が薬液注入システム市場全体を独占すると予測されます。

すべての地域の中で、北米が薬液注入システム市場で最大のシェアを占めると予測されます。慢性腰痛、糖尿病、がんなどの慢性疾患の流行、確立された医療制度、主要市場企業のプレゼンスなどが、予測期間に薬液注入システム市場全体の成長を促進する主な影響要因になると予測されます。

疾病予防管理センター（CDC）が提供した情報では、National Health Survey 2019によると、2019年までに成人の約20.4％が慢性疼痛を有し、成人の7.4％が仕事や生活活動を頻繁に制限する慢性疼痛（高負荷慢性疼痛と見なされる）を有していました。この調査では、高負荷の慢性疼痛と慢性疼痛は、65歳以上の人により大きく影響し、年齢とともに悪化することが考察されました。

当レポートでは、世界の薬液注入システム市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 薬液注入システム市場レポートのイントロダクション

第2章 薬液注入システム市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 薬液注入システム市場の主な要因の分析

  • 薬液注入システム市場の促進要因
    • 慢性疾患の有病率の増加
    • がんの有病率の増加
    • 老年人口の増加
    • 製品開発における技術革新
  • 薬液注入システム市場の抑制要因と課題
    • 頻繁な製品リコール
    • デバイスに関連する技術的課題
  • 薬液注入システム市場の機会
    • 製品の安全性の向上
    • 製品設計の改良

第5章 薬液注入システム市場のポーターのファイブフォース分析

第6章 薬液注入システム市場のレイアウト

  • 製品タイプ別
    • シリンジ注入システム
    • エラストマー注入システム
    • 大容量注入システム
    • 経腸注入システム
    • PCA注入システム
    • インスリンポンプ
    • その他
  • 製品配置別
    • 体外式
    • 植込み式
  • 可動性別
    • 固定式
    • 移動式
  • 用途別
    • 腫瘍治療
    • 糖尿病
    • 鎮痛
    • 栄養
  • エンドユーザー別
    • 病院
    • 外来手術センター
    • 在宅ケア環境
  • 地域別
    • 北米の薬液注入システムの市場規模（2021年～2030年）
    • 欧州の薬液注入システムの市場規模（2021年～2030年）
    • アジア太平洋の薬液注入システムの市場規模（2021年～2030年）
    • その他の地域の薬液注入システムの市場規模（2021年～2030年）

第7章 薬液注入システム市場の企業と製品のプロファイル

  • B. Braun Melsungen AG
  • Medtronic
  • BD
  • PROMECON GmbH
  • arcomed ag
  • Fresnius Kabi AG
  • Microport Scientific Corporation
  • Teleflex Incorporated
  • Smiths Medical
  • Baxter
  • Ivenix Inc
  • Terumo Corporation
  • Insulet Corporation
  • FLOWONIX MEDICAL INC
  • Intera Oncology

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Drug Infusion Systems Market in Global (2021-2030)
  • Table 3: Drug Infusion Systems Market in Global by Product Type (2021-2030)
  • Table 4: Drug Infusion Systems Market in Global by Product Placement (2021-2030)
  • Table 5: Drug Infusion Systems Market in Global by Portability (2021-2030)
  • Table 6: Drug Infusion Systems Market in Global by Application (2021-2030)
  • Table 7: Drug Infusion Systems Market in Global by End-User (2021-2030)
  • Table 8: Drug Infusion Systems Market in Global by Geography (2021-2030)
  • Table 9: Drug Infusion Systems Market in North America (2021-2030)
  • Table 10: Drug Infusion Systems Market in the US (2021-2030)
  • Table 11: Drug Infusion Systems Market in Canada (2021-2030)
  • Table 12: Drug Infusion Systems Market in Mexico (2021-2030)
  • Table 13: Drug Infusion Systems Market in Europe (2021-2030)
  • Table 14: Drug Infusion Systems Market in France (2021-2030)
  • Table 15: Drug Infusion Systems Market in Germany (2021-2030)
  • Table 16: Drug Infusion Systems Market in the United Kingdom (2021-2030)
  • Table 17: Drug Infusion Systems Market in Italy (2021-2030)
  • Table 18: Drug Infusion Systems Market in Spain (2021-2030)
  • Table 19: Drug Infusion Systems Market in Rest of Europe (2021-2030)
  • Table 20: Drug Infusion Systems Market in Asia-Pacific (2021-2030)
  • Table 21: Drug Infusion Systems Market in China (2021-2030)
  • Table 22: Drug Infusion Systems Market in Japan (2021-2030)
  • Table 23: Drug Infusion Systems Market in India (2021-2030)
  • Table 24: Drug Infusion Systems Market in Australia (2021-2030)
  • Table 25: Drug Infusion Systems Market in South Korea (2021-2030)
  • Table 26: Drug Infusion Systems Market in Rest of Asia-Pacific (2021-2030)
  • Table 27: Drug Infusion Systems Market in Rest of World (2021-2030)
  • Table 28: Drug Infusion Systems Market in the Middle East (2021-2030)
  • Table 29: Drug Infusion Systems Market in Africa (2021-2030)
  • Table 30: Drug Infusion Systems Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Drug Infusion Systems Market in Global (2021-2030)
  • Figure 3: Drug Infusion Systems Market in Global by Product Type (2021-2030)
  • Figure 4: Drug Infusion Systems Market in Global by Product Placement (2021-2030)
  • Figure 5: Drug Infusion Systems Market in Global by Portability (2021-2030)
  • Figure 6: Drug Infusion Systems Market in Global by Application (2021-2030)
  • Figure 7: Drug Infusion Systems Market in Global by End-User (2021-2030)
  • Figure 8: Drug Infusion Systems Market in Global by Geography (2021-2030)
  • Figure 9: Drug Infusion Systems Market in North America (2021-2030)
  • Figure 10: Drug Infusion Systems Market in the US (2021-2030)
  • Figure 11: Drug Infusion Systems Market in Canada (2021-2030)
  • Figure 12: Drug Infusion Systems Market in Mexico (2021-2030)
  • Figure 13: Drug Infusion Systems Market in Europe (2021-2030)
  • Figure 14: Drug Infusion Systems Market in France (2021-2030)
  • Figure 15: Drug Infusion Systems Market in Germany (2021-2030)
  • Figure 16: Drug Infusion Systems Market in the United Kingdom (2021-2030)
  • Figure 17: Drug Infusion Systems Market in Italy (2021-2030)
  • Figure 18: Drug Infusion Systems Market in Spain (2021-2030)
  • Figure 19: Drug Infusion Systems Market in Rest of Europe (2021-2030)
  • Figure 20: Drug Infusion Systems Market in Asia-Pacific (2021-2030)
  • Figure 21: Drug Infusion Systems Market in China (2021-2030)
  • Figure 22: Drug Infusion Systems Market in Japan (2021-2030)
  • Figure 23: Drug Infusion Systems Market in India (2021-2030)
  • Figure 24: Drug Infusion Systems Market in Australia (2021-2030)
  • Figure 25: Drug Infusion Systems Market in South Korea (2021-2030)
  • Figure 26: Drug Infusion Systems Market in Rest of Asia-Pacific (2021-2030)
  • Figure 27: Drug Infusion Systems Market in the Rest of the World (2021-2030)
  • Figure 28: Drug Infusion Systems Market in the Middle East (2021-2030)
  • Figure 29: Drug Infusion Systems Market in Africa (2021-2030)
  • Figure 30: Drug Infusion Systems Market in South America (2021-2030)
  • Figure 31: Market Drivers
  • Figure 32: Market Barriers
  • Figure 33: Marker Opportunities
  • Figure 34: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0039

Drug Infusion Systems Market By Product Type (Syringe Infusion Systems, Elastomeric Infusion Systems, Large Volume Infusion Systems, Enteral Infusion Systems, Patient-Controlled Analgesic Infusion Systems, Insulin Pumps, and Others), Product Placement (External and Implantable), Portability (Fixed and Ambulatory), Application (Oncotherapy, Diabetes, Analgesia, Nutrition, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of chronic diseases and increasing technological advancements

The global drug infusion systems market was valued at USD 11.73 billion in 2023, growing at a CAGR of 8.85% during the forecast period from 2024 to 2030 to reach USD 19.45 billion by 2030. The demand for drug infusion systems is primarily being boosted by the rising prevalence of chronic diseases such as cancer, diabetes, and others coupled with the increasing geriatric population and technological advancements in product development among others.

Drug Infusion Systems Market Dynamics:

The drug infusion systems market is slated to register significant growth in the forecast period due to the rising prevalence of various cancers and other chronic diseases. For instance, according to the data cited by the World Health Organization (WHO) 2022, worldwide around 2.26 million cases of breast, 2.21 million cases of lung, 1.93 million cases of colon and rectum, 1.41 million cases of prostate, and 1.09 million cases of stomach cancer were reported in 2020.

As per the statistics published by the International Diabetes Federation (IDF) (2023), worldwide 537 million adults were living with diabetes in 2021. This number is predicted to rise to 643 million by 2030 and 783 million by 2045.

The above-mentioned facts are examples of cancers and chronic diseases that are witnessing a rapid increase across the globe. Chronic diseases often impact individuals for the course of their lifetime and require therapeutic interventions for prolonged periods. To achieve that, drug infusion systems are used. Drug infusion systems are medical devices that are employed in the delivery of drugs such as antibiotics, pain relievers, hormones, and chemotherapy drugs as well as nutrients to the patients. These systems are available in various configurations such as stationary as well ambulatory ones. These devices offer a safe and accurate mode of drug delivery without the constant need for verifying the amount of dose being administered.

Moreover, technological advancements have led to the development of programmable drug infusion systems where flow rates and alarms among other features are being offered for easy tracking of the administered doses. For instance, the Space ecosystem by B. Braun Melsugen AG is an integrated infusion system that comes with the OnlineSuiteplus. This integrated system offers features such as connectivity and data management and standardized interoperability, outstanding therapy, and cloud-based applications among other features.

However, product recalls as well as technical problems associated with infusion systems such as disconnection, and issues in calibration may prove to be certain restraints to the drug infusion systems market growth.

Drug Infusion Systems Market Segment Analysis:

Drug Infusion Systems Market by Product Type (Syringe Infusion Systems, Elastomeric Infusion Systems, Large-Volume Infusion Systems, Enteral Infusion Systems, Patient-Controlled Analgesic Infusion Systems, Insulin Pumps, and Others), Product Placement (External and Implantable), Portability (Fixed and Ambulatory), Application (Oncotherapy, Diabetes, Analgesia, Nutrition, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment in the drug infusion systems market, syringe-based infusion systems are estimated to account for a significant share of the market.

This is due to their simple product design and wide applicability.

Syringe pumps are extensively used in clinical settings as the majority of the medications are available in syringe forms. Therefore, a syringe is fitted into the system and programmed for the delivery of the drug as per the requirement.

These systems are useful in the delivery of low medication volumes for medication required in small quantities.

Syringe infusion systems are particularly ideal for dose administration in younger patients such as babies, neonates, and young children.

Hence, owing to the advantages offered by syringe infusion systems, their demand will increase during the forecast period.

North America is expected to dominate the Overall Drug Infusion Systems Market:

Among all the regions, North America is expected to account for the largest share of the drug infusion systems market. The growing prevalence of chronic diseases such as chronic low back pain, diabetes, and cancers, a well-established healthcare system along with the presence of major market players in the region are predicted to be the major influencing factors in driving the overall growth of the drug infusion systems market over the forecast period.

As per the facts provided by the Centers for Disease Prevention and Control (CDC), according to the National Health Survey 2019, about 20.4% of adults had chronic pain and 7.4% of adults had chronic pain that frequently limited work or life activities (considered as high impact chronic pain) in 2019. It was observed in the survey that high-impact chronic pain and chronic pain affected people over 65 and above more commonly and worsen with age.

As per the figures mentioned by the American Cancer Society 2021, it was estimated that 1.9 million new cancer cases have been diagnosed in the United States in 2021. Also, according to the data provided by the CDC in 2021, around 1,752,735 new cases of cancer were reported in the US in 2019. As per Globocan 2021 data, there were around 61,152 new cases of leukemia recorded in 2020 in the United States.

As these indications require long-term disease management, drug infusion systems prove to be extremely useful devices in the administration of pain management therapies as well as chemotherapy.

Moreover, the US houses a large number of key players in the market which can be attributed to the conducive product development environment along with better opportunities in terms of market access to the end users.

In June 2019, Ivenix Inc received 510k approval from the US Food and Drug Administration for their Ivenix Infusion System, which was the first and only large-volume pump and infusion system designed with the new FDA infusion guidelines, first adopted in 2014.

Therefore, with the presence of a large patient pool, along with an active regulatory body as well as active key market players in the country and the region, the market outlook for drug infusion systems is expected to be promising in the US and North America.

Drug Infusion Systems Market Key Players:

Some of the key market players operating in the drug infusion systems market include B. Braun Melsungen AG, Medtronic, BD, PROMECON GmbH, arcomed ag, Fresenius Kabi AG, Microport Scientific Corporation, Teleflex Incorporated., Smiths Medical, Baxter, Ivenix Inc, Terumo Corporation, Insulet Corporation., FLOWONIX MEDICAL INC, Intera Oncology and others.

Recent Developmental Activities in Drug Infusion Systems Market:

In September 2020, B. Braun Melsungen received 510k clearance from the US FDA for their SpaceStation MRI to allow Space® infusion pumps. These systems are meant for the delivery of medications to patients within the MRI suites.

In May 2020, Baxter received the CE mark approval and regulatory approval from Australia's Therapeutic Goods Administration (TGA) for their Evo IQ Syringe Infusion System. The system can be employed in the delivery of small volumes of fluids and other medications to patients in a controlled manner.

Key Takeaways from the Drug Infusion Systems Market Report Study

Market size analysis for current drug infusion systems market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global drug infusion systems market.

Various opportunities available for the other competitor in the drug infusion systems market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current drug infusion systems market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for drug infusion systems market growth in the coming future?

Target Audience who can be benefited from this Drug Infusion Systems Market Report Study

Drug infusion systems products providers

Research organizations and consulting companies

Drug infusion systems-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in drug infusion systems

Various End-Users who want to know more about the drug infusion systems market and the latest technological developments in the drug infusion systems market.

Frequently Asked Questions for Drug Infusion Systems Market:

1. What are drug infusion systems?

Drug Infusion Systems are medical devices that help in the administration of drugs such as pain relievers, antibiotics, and chemotherapy drugs to patients. These systems are also used in the administration of nutrients as well.

2. What is the market for global drug infusion systems?

The global drug infusion systems market was valued at USD 11.73 billion in 2023, growing at a CAGR of 8.85% during the forecast period from 2024 to 2030 to reach USD 19.45 billion by 2030.

3. What are the drivers for the global drug infusion systems market?

Some of the factors positively influencing the drug infusion systems market are the increasing prevalence of chronic diseases, and various cancers, the rising geriatric population, and technological advancement in product development.

4. Who are the key players operating in global drug infusion systems?

Some of the prominent market players operating in the drug infusion systems market include B. Braun Melsungen AG, Medtronic, BD, PROMECON GmbH, arcomed ag, Fresenius Kabi AG, Microport Scientific Corporation, Teleflex Incorporated., Smiths Medical, Baxter, Ivenix Inc, Terumo Corporation, Insulet Corporation., FLOWONIX MEDICAL INC, Intera Oncology and others.

5. Which region has the highest share in the drug infusion systems market?

North America is expected to account for the highest revenue share in the drug infusion systems market during the forecast period. Factors such as access to better healthcare, a rising number of patients suffering from chronic diseases such as diabetes, and chronic back pain, and increasing product launches in the region are expected to drive the growth of the North American Drug Infusion Systems market.

Table of Contents

1. Drug Infusion Systems Market Report Introduction

2. Drug Infusion Systems Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Drug Infusion Systems Market Key Factors Analysis

  • 4.1. Drug Infusion Systems Market Drivers
    • 4.1.1. Increasing Prevalence of Chronic Diseases
    • 4.1.2. Rising Prevalence of Cancers
    • 4.1.3. Increasing Geriatric Population
    • 4.1.4. Technological Innovation in Product Development
  • 4.2. Drug Infusion Systems Market Restraints and Challenges
    • 4.2.1. Frequent Product Recalls
    • 4.2.2. Technical Challenges Associated with Devices
  • 4.3. Drug Infusion Systems Market Opportunities
    • 4.3.1. Improving Product Safety
    • 4.3.2. Improvement in Product Design

5. Drug Infusion Systems Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Drug Infusion Systems Market Layout

  • 6.1. By Product Type
    • 6.1.1. Syringe Infusion Systems
    • 6.1.2. Elastomeric Infusion Systems
    • 6.1.3. Large-Volume Infusion Systems
    • 6.1.4. Enteral Infusion Systems
    • 6.1.5. PCA Infusion Systems
    • 6.1.6. Insulin Pumps
    • 6.1.7. Others
  • 6.2. By Product Placement
    • 6.2.1. External
    • 6.2.2. Implantable
  • 6.3. By Portability
    • 6.3.1. Stationary
    • 6.3.2. Ambulatory
  • 6.4. By Application
    • 6.4.1. Oncotherapy
    • 6.4.2. Diabetes
    • 6.4.3. Analgesia
    • 6.4.4. Nutrition
    • 6.4.5. Others
  • 6.5. By End-User
    • 6.5.1. Hospitals
    • 6.5.2. Ambulatory Surgical Centers
    • 6.5.3. Homecare Settings
    • 6.5.4. Others
  • 6.6. By Geography
    • 6.6.1. North America Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.1.1. United States Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.1.2. Canada Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.1.3. Mexico Drug Infusion Systems Market Size in USD million (2021-2030)
    • 6.6.2. Europe Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.2.1. France Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.2.2. Germany Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.2.3. United Kingdom Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.2.4. Italy Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.2.5. Spain Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.2.6. Rest of Europe Drug Infusion Systems Market Size in USD million (2021-2030)
    • 6.6.3. Asia-Pacific Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.3.1. China Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.3.2. Japan Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.3.3. India Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.3.4. Australia Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.3.5. South Korea Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.3.6. Rest of Asia Pacific Drug Infusion Systems Market Size in USD million (2021-2030)
    • 6.6.4. Rest of the World (RoW) Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.4.1. Middle East Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.4.2. Africa Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.4.3. South America Drug Infusion Systems Market Size in USD million (2021-2030)

7. Drug Infusion Systems Market Company and Product Profiles

  • 7.1. B. Braun Melsungen AG
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Medtronic
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. BD
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. PROMECON GmbH
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. arcomed ag
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Fresnius Kabi AG
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Microport Scientific Corporation
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Teleflex Incorporated
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Smiths Medical
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Baxter
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Ivenix Inc
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Terumo Corporation
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Insulet Corporation
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. FLOWONIX MEDICAL INC
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Intera Oncology
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us